8 December 2020
We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...
3 February 2020
NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.
Surveillance of gender identity disorder concluded in May 2013. This study was a dual surveillance project collecting data both through the British Paediatric Surveillance Unit (BPSU) and the Child and Adolescent Psychiatric Surveillance System (CAPSS) at the Royal College of Psychiatrists. The stud...